Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04038515 · ClinicalTrials.gov registry record · Phase 2

Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes

A Phase 2 study, sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase
54
Enrollment target

NCT04038515 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04038515, a Phase 2 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase
54 participants
Enrollment target

Study Summary

The goal of this application is to test whether menthol and fruit flavors impact e-cigarette use through dissociable mechanisms and exert their effects differentially across nicotine doses.

Interventions

  • DRUG Nicotine 0 mg/mL
  • DRUG Nicotine 6 mg/mL
  • DRUG Nicotine 12 mg/mL
  • DRUG Nicotine 24 mg/mL
  • OTHER 'Menthol' flavor

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2022-10-27
Est. Completion 2024-06-03
Phase Phase 2

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04038515

The ClinicalTrials.gov registry entry for NCT04038515 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Nicotine 0 mg/mL is the first listed.

NCT04038515 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04038515 about?

NCT04038515 is a clinical study titled "Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes". The goal of this application is to test whether menthol and fruit flavors impact e-cigarette use through dissociable mechanisms and exert their effects differentially across nicotine doses.

What is the current status of trial NCT04038515?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2022-10-27. Estimated completion is 2024-06-03.

What interventions are being tested in trial NCT04038515?

The interventions under investigation include: Nicotine 0 mg/mL (DRUG), Nicotine 6 mg/mL (DRUG), Nicotine 12 mg/mL (DRUG), Nicotine 24 mg/mL (DRUG), 'Menthol' flavor (OTHER).

Who is sponsoring clinical trial NCT04038515?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.